Longevity scienceHealth techBiomedicine

Ray and Terry's

Live Well Forever

A techno-optimistic watchtower for living longer by making health measurable, repairable and increasingly programmable.

3.0Kposts
1topics
1languages
The curator

A longevity futurist with a biomedical radar

Ray and Terry's is a long-running English-language Scoop.it presence devoted to longevity science and health technology. Since 2012, it has gathered thousands of items around one clear proposition: healthy aging depends on tracking the technologies and biological discoveries that may extend healthspan.

The bridge-to-the-future premise

The bio names Ray Kurzweil and Terry Grossman, and the topic reflects their familiar premise: live well now so that later technologies can extend healthy life further. The result is a practical futurist lens on medicine.

A quiet but legible voice

There is little visible commentary in the sample. The editorial personality comes through by choice and repetition: brain prosthetics, CRISPR, inflammation switches, diabetic sensors and cancer combinations all point to a mind scanning for usable progress.

A public appetite for engineered health

More than 90,000 views and over 40,000 unique visitors suggest a readership drawn to health technology as much as to longevity itself. The audience is being served a continuous feed of reasons to think biology is becoming more programmable.

What defines this selection

Long horizon, steady watch

With 3,001 posts in a single topic since 2012, the work has the feel of a long-running observatory. It tracks the slow accumulation of biomedical signals rather than a short campaign of headlines.

From paper to patient

The strongest thread is translational medicine: devices, diagnostics, drugs, sensors, prosthetics and platforms that could move from lab news into care. The selection favors breakthroughs with possible use in the near future.

A broad healthspan map

The topic joins anti-aging biology with adjacent technologies such as CRISPR, wearables, prosthetics and health data systems. Longevity is presented as an ecosystem, not a single pill or theory.

Optimism with caveats

The source mix and titles lean optimistic, but the selection still includes uncertainty, debate and regulation. Controversies around neurogenesis, gene editing and biotech policy keep the future grounded in evidence and constraint.

Topics

Deep dives

Healthspan as an engineering project

The central idea is practical futurism: stay healthy long enough to benefit from the next wave of medicine. The topic treats longevity less as a dream of immortality than as an engineering problem, where brain prosthetics, diagnostics, sensors and regenerative tools become part of ordinary health maintenance.

Aging biology is followed through mechanisms that can be tested and measured. Inflammation, metabolism, caloric restriction, neurogenesis and biological age all appear as levers, not abstractions. The emphasis is on findings that might translate into interventions.

Disease coverage is folded into the same long-life argument. Cancer, Alzheimer’s, diabetes, stroke and chronic inflammation appear because better treatment of major diseases is part of extending healthspan. The strongest pattern is not novelty for its own sake, but near-term biomedical usefulness.

The topic also watches the infrastructure around future medicine: CRISPR policy, biotech drugs, blockchain in healthcare and platform technologies. This gives the selection a wider horizon than anti-aging advice alone; it follows the systems that could make health innovation scalable.

Selected posts